• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱、输尿管及肾盂癌标本的处理与病理报告

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

作者信息

Lopez-Beltran Antonio, Bassi PierFrancesco, Pavone-Macaluso Michele, Montironi Rodolfo

机构信息

Department of Pathology, Unit of Anatomic Pathology, Faculty of medicine, Cordoba University Medical School, Avda. Menendez-Pidal S/N, 14004 Cordoba, Spain.

出版信息

Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018.

DOI:10.1016/j.eururo.2003.09.018
PMID:15036668
Abstract

OBJECTIVE

Pathologists play a pivotal role in the diagnosis and in the report of the pathological features related to prognosis.

METHODS

To meet these endpoints, the following issues must be accomplished: adequate information about the patient history, proper handling of the specimens, identification of the reliable histopathological techniques necessary to reach the more detailed diagnostic information and evaluate the prognostic variables, and a standardized pathological report.

RESULTS

Recent efforts to standardize the histopathological evaluation have generated significant confusion among the urological and pathological communities as well. No consensus has been achieved about the optimal pathological grading of urothelial tumors, to date.

CONCLUSION

A proposal for standardization of sampling and reporting of the urothelial tissues achieved within Uropathology follows. The urologists have a great role in assisting pathologists in the proper examination by providing them with clinical information.

摘要

目的

病理学家在诊断以及与预后相关的病理特征报告中发挥着关键作用。

方法

为实现这些目标,必须完成以下事项:获取关于患者病史的充分信息、妥善处理标本、确定获取更详细诊断信息并评估预后变量所需的可靠组织病理学技术,以及生成标准化的病理报告。

结果

近期使组织病理学评估标准化的努力在泌尿外科和病理学界也引发了极大困惑。迄今为止,关于尿路上皮肿瘤的最佳病理分级尚未达成共识。

结论

以下是尿路上皮病理学领域内实现尿路上皮组织采样和报告标准化的提议。泌尿外科医生在通过向病理学家提供临床信息协助其进行恰当检查方面发挥着重要作用。

相似文献

1
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.膀胱、输尿管及肾盂癌标本的处理与病理报告
Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018.
2
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.膀胱、输尿管及肾盂癌标本的处理与病理报告。欧洲泌尿病理学会和泌尿病理工作组联合提议
Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8.
3
Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.上尿路肿瘤:一项综述,重点关注肾盂肾盏系统的尿路上皮癌及其诊断和报告相关方面。
Adv Anat Pathol. 2008 May;15(3):127-39. doi: 10.1097/PAP.0b013e31817145a9.
4
Pathology and staging of urothelial tumors of the kidney and ureter.肾和输尿管尿路上皮肿瘤的病理学及分期
Urol Clin North Am. 1993 May;20(2):333-47.
5
[Upper urinary tract tumors pathology (ureter, pelvis and renal calyces)].[上尿路肿瘤病理学(输尿管、肾盂和肾盏)]
Arch Esp Urol. 2004 Apr;57(3):241-50.
6
Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.肾盂和输尿管鳞状细胞癌:发病率、症状、治疗及预后
J Urol. 2007 Jul;178(1):51-6. doi: 10.1016/j.juro.2007.03.033. Epub 2007 May 11.
7
Consideration for treatment of upper urinary tract tumors with topical therapy.关于采用局部治疗方法治疗上尿路肿瘤的考量。
Urology. 1985 Oct;26(4 Suppl):47-50.
8
Some observations on the pathology and natural history of urothelial neoplasms.关于尿路上皮肿瘤的病理学及自然史的一些观察
Beitr Pathol. 1972;145(4):325-35.
9
Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.尿路上皮癌的监测:1993 - 2005年分期和分级变化以及1993 - 2000年生存趋势
Cancer. 2009 Apr 1;115(7):1435-47. doi: 10.1002/cncr.24147.
10
Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.肾盂和输尿管移行细胞癌:台湾人群的比较人口统计学特征、病理分级和分期以及5年生存率
BJU Int. 2009 Feb;103(3):312-6. doi: 10.1111/j.1464-410X.2008.07985.x. Epub 2008 Sep 8.

引用本文的文献

1
Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.根治性膀胱切除术后 1 年内骨骼肌指数下降可作为膀胱癌患者的预后指标。
Int Braz J Urol. 2019 Jul-Aug;45(4):686-694. doi: 10.1590/S1677-5538.IBJU.2018.0530.
2
Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.根治性膀胱切除术后膀胱癌患者的德瑞蒂斯比值(天冬氨酸氨基转移酶/丙氨酸氨基转移酶)与肿瘤学结局之间的关联
BMC Urol. 2019 Jan 24;19(1):10. doi: 10.1186/s12894-019-0439-7.
3
Outcomes of stage II-IV upper-tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer.
II-IV期上尿路尿路上皮癌的治疗结果及局部晚期癌症的辅助化疗
Oncol Lett. 2019 Jan;17(1):1341-1348. doi: 10.3892/ol.2018.9672. Epub 2018 Nov 7.
4
Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma.比较开放手术、腹腔镜手术和机器人辅助腹腔镜手术治疗非转移性上尿路尿路上皮癌的肿瘤学和围手术期结果。
PLoS One. 2019 Jan 8;14(1):e0210401. doi: 10.1371/journal.pone.0210401. eCollection 2019.
5
A practical guide to bladder cancer pathology.膀胱癌病理学实用指南。
Nat Rev Urol. 2018 Mar;15(3):143-154. doi: 10.1038/nrurol.2018.2. Epub 2018 Jan 31.
6
Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma.铜转运蛋白1表达在透明细胞肾细胞癌患者中的预后价值
Oncol Lett. 2017 Nov;14(5):5791-5800. doi: 10.3892/ol.2017.6942. Epub 2017 Sep 14.
7
Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review.膀胱经尿道切除术中尿路上皮癌复发的组织病理学演变:35例连续病例及文献综述
Asian Pac J Cancer Prev. 2017 Feb 1;18(2):459-463. doi: 10.22034/APJCP.2017.18.2.459.
8
Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.现代病理学中肿瘤内异质性的检测:多部位肿瘤采样视角
Front Med (Lausanne). 2017 Mar 6;4:25. doi: 10.3389/fmed.2017.00025. eCollection 2017.
9
Serum metabolomic analysis of human upper urinary tract urothelial carcinoma.人上尿路尿路上皮癌的血清代谢组学分析
Tumour Biol. 2015 Sep;36(10):7531-7. doi: 10.1007/s13277-015-3482-3. Epub 2015 Apr 28.
10
TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR.端粒酶逆转录酶(TERT)启动子突变与上尿路尿路上皮癌的远处转移相关,并作为通过敏感的铸型聚合酶链反应(castPCR)检测到的尿液生物标志物。
Oncotarget. 2014 Dec 15;5(23):12428-39. doi: 10.18632/oncotarget.2660.